wellrank.ai
EstroGel logo

EstroGel

First cited by AI Jun 11, 2026
estrogel.com

Surfaced organically in AI answers about menopause and women's health. Not yet profiled.

AI Visibility

Visibility trend

Menopause and women's health, daily share of AI answers mentioning EstroGel, through Jun 13, 2026.

8.3%

Avg position when mentioned: 4.0

By engine

Where EstroGel is strong, and where it is invisible.

  • Claude
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 2 positive mentions
  • 1 neutral
  • 0 mixed or cautious

Recent AI answers mentioning EstroGel

ClaudeJun 13, 2026, 11:06 UTC
Bioidentical hormones vs standard HRT: what is the difference?

Bioidentical Hormones vs. Standard HRT Standard HRT These are FDA-approved hormone medications that may include: Synthetic hormones (like medroxyprogesterone acetate) or Horse-derived estrogens (like Premarin, from pregnant mare urine) Consistent, tested dosing Bioidentical Hormones Hormones chemically identical to those your body naturally produces, derived from plant sources (soy/yams). Two Categories of Bioidentical Options FDA-Approved Bioidentical Products (generally recommended) Estradiol patches – Vivelle-Dot, Climara Estradiol gels – EstroGel, Divigel Progesterone – Prometrium (oral capsule) These have standardized dosing and safety testing Compounded Bioidentical Hormones (more controversial) Custom-mixed by compounding pharmacies Often marketed as "natural" and personalized Not FDA-approved for safety/efficacy Quality can vary significantly between pharmacies Key Considerations FDA-approved bioidentical options offer the best of both worlds - natural molecular structure with proven safety data Most major medical organizations do not recommend compounded versions over regulated alternatives Always consult an endocrinologist or menopause specialist for personalized guidance The marketing around "bioidentical" can be misleading - FDA-approved options are your safest starting point.

Mentioned in position 4 of 6

Read full answer with sources →
ChatGPTJun 12, 2026, 10:14 UTC
What is BHRT and how do I know if I need it?

Short answer BHRT = bioidentical hormone replacement therapy. It means giving hormones that are chemically identical to the hormones your body makes (for example 17β‑estradiol, progesterone, testosterone) to treat symptoms of hormone deficiency. Whether you “need” it depends on your symptoms, medical history, and risks — discuss this with a clinician. What BHRT is (brief) “Bioidentical” refers to the chemical structure being the same as human hormones (not necessarily that it’s safer). BHRT can be delivered as FDA‑approved products (estradiol patches, micronized progesterone capsules, transdermal testosterone products, vaginal estrogen tablets/creams/rings) or as custom‑compounded preparations (creams, pellets, troches). Common targets: menopausal/perimenopausal symptoms (hot flashes, night sweats), vulvovaginal atrophy, sexual dysfunction, and symptomatic low testosterone in men. When BHRT might help Moderate–severe vasomotor symptoms (hot flashes/night sweats) that affect quality of life. Genitourinary syndrome of menopause (vaginal dryness, painful intercourse) — local vaginal estrogen often works well. Premature ovarian insufficiency or surgical menopause (younger people often benefit from hormonal replacement). Men with documented symptomatic low testosterone (confirmed by morning labs and appropriate evaluation). How clinicians decide (testing and assessment) Start with a symptom history, menstrual pattern/age, and medical risk assessment (breast cancer history, clotting disorders, CVD, liver disease, etc.). Common labs: for women — FSH and estradiol (sometimes); for men — morning total testosterone, maybe free testosterone, LH, prolactin, PSA and hematocrit before/during therapy. Beware: saliva hormone tests are not reliable for guiding systemic therapy; blood tests are preferred. You don’t always need labs if a woman is >50 with classic menopausal symptoms; labs are more helpful in atypical cases or younger patients. Benefits vs risks (important) Benefits: relief of hot flashes, improved sleep/mood for some people, vaginal symptom relief, prevention of bone loss if indicated. Risks: similar to conventional HRT — possible increased risk of thromboembolism, stroke, and (depending on hormone type and duration) breast cancer; risk depends on age, dose, route (transdermal estrogen has lower VTE risk than oral), and whether progesterone is used in women with a uterus. Compounded BHRT has less regulatory oversight and variable dosing/purity; safety and efficacy data are more limited. Pellet therapy and unmonitored dosing are associated with higher adverse-event concerns in some reports. Practical guidance — how to proceed Make an appointment with a clinician experienced in menopause or hormone therapy (OB/GYN, reproductive endocrinologist, internist trained in menopause). You can search for a NAMS Certified Menopause Practitioner (NCMP) through the North American Menopause Society (NAMS). Discuss symptoms, medical history, and your goals. Ask about nonhormonal options if you have contraindications. If hormone therapy is appropriate, prefer FDA‑approved, standard formulations first (they have known dosing, quality control, and safety data). Consider transdermal estradiol if you have clotting risk. If considering compounded BHRT, ask why a standard FDA product won’t work, insist on blood testing (not saliva) and on using a reputable, licensed compounding pharmacy that follows USP standards. Be aware of limited oversight and evidence. Specific products and resources (examples) FDA‑approved bioidentical options: estradiol patches (Vivelle‑Dot, Climara), estradiol gels (EstroGel, Divigel), vaginal products (Vagifem tablets, Estrace cream, Estring ring), micronized progesterone (Prometrium). For male testosterone replacement: AndroGel, Testim, Axiron (prescription testosterone products — use requires proper testing and monitoring). Trusted information and clinician search: North American Menopause Society (menopause.org), Endocrine Society guidelines, Mayo Clinic and Cleveland Clinic patient pages. Labs: common national labs (Quest Diagnostics, LabCorp) for reliable serum testing. When not to use BHRT Active, untreated breast cancer or certain other estrogen‑sensitive cancers, active blood clots, unexplained vaginal bleeding, pregnancy. Decisions should be individualized for people with history of breast cancer — discuss risks with an oncologist. If you want next steps Tell me: your age, sex, main symptoms, any major medical history (breast cancer, clotting, heart disease), and whether you’ve had any hormone tests — I can suggest what to ask your clinician and which labs would be reasonable.

Mentioned in position 3 of 14

Read full answer with sources →
ChatGPTJun 11, 2026, 20:08 UTC
I am 47 with hot flashes and terrible sleep. What are my treatment options?

Short answer If your hot flashes are frequent/intense and they’re what’s wrecking your sleep, menopausal hormone therapy (MHT, i.e., estrogen ± a progestogen) is the single most effective treatment for both vasomotor symptoms and the sleep problems they cause — provided you don’t have contraindications. If you can’t or don’t want hormones, there are effective non‑hormonal drug and behavioral options (antidepressants, gabapentin, CBT‑I, cooling strategies, etc.). Below is a practical, clinician‑friendly summary of options, pros/cons, and specific products/brands to discuss with your doctor. 1) Menopausal hormone therapy (MHT) — most effective What it treats: Hot flashes, night sweats, and related sleep disruption; it often improves mood and vaginal symptoms as well. Who it’s best for: Generally recommended for women with moderate–severe vasomotor symptoms without major contraindications (history of breast cancer, active liver disease, known clotting disorders, recent stroke/heart attack). Regimens/routes: Systemic estrogen (works best for hot flashes): oral (Estrace, Premarin) or transdermal patch/gel. Transdermal estradiol patches/gels (Vivelle‑Dot, Climara, EstroGel) may have lower risk of blood clots than oral estrogen and are often preferred if you have migraine with aura or higher clot risk. If you have a uterus, you also need a progestogen to protect the lining of the uterus: micronized progesterone (Prometrium) or medroxyprogesterone (Provera) are common. Another option is an intrauterine levonorgestrel device (Mirena) for local progestin. Risks: small increased risks of breast cancer with long‑term combined use, and of VTE/stroke (risk varies by age, time since menopause, route of administration). Use the lowest effective dose for the shortest period needed; many women use it for several years with regular re‑evaluation. 2) Non‑hormonal prescription options (if hormones aren’t appropriate or desired) SSRIs/SNRIs: Paroxetine 7.5 mg (Brisdelle) is FDA‑approved for hot flashes. Note: paroxetine and fluoxetine strongly inhibit CYP2D6 and can interfere with tamoxifen — avoid if you’re taking tamoxifen. Venlafaxine (Effexor) and desvenlafaxine are commonly used and effective for hot flashes; can improve sleep in some women. Gabapentin (Neurontin): often used at bedtime (typical effective total daily doses 300–900 mg) and especially helpful for nighttime hot flashes and sleep. Pregabalin (Lyrica) also effective but is a controlled medication and typically considered after others. Clonidine (Catapres): modest benefit, sometimes used if other options fail. Choice depends on comorbidities (anxiety, depression, insomnia), side‑effect profile, and drug interactions. 3) Treatments targeted primarily at sleep Cognitive behavioral therapy for insomnia (CBT‑I) is first‑line for chronic insomnia and effective long term. Digital programs (e.g., Sleepio) or a behavioral sleep specialist are options. Sleep medications for short‑term use: zolpidem (Ambien) or zaleplon; low‑dose doxepin (Silenor) or trazodone are alternatives; ramelteon (Rozerem) is a melatonin receptor agonist. Avoid chronic benzodiazepine/Z‑drug use if possible. Melatonin (over the counter) can help some people with sleep onset. 4) Lifestyle, behavioral, and practical measures Identify and avoid hot‑flash triggers (alcohol, spicy foods, caffeine, hot rooms). Dress in layers, use fans, keep bedroom cool, moisture‑wicking sleepwear/bedding. Nighttime cooling options: bedside fan, cooling mattress pads/pillows, breathable sheets. Exercise regularly (not right before bed), maintain good sleep hygiene, practice relaxation/breathing techniques for nighttime awakenings. Some women benefit from paced breathing, mindfulness, or CBT for menopausal symptoms. 5) Complementary/alternative interventions — limited evidence Soy/phytoestrogens, black cohosh, and other supplements show mixed results; black cohosh has safety concerns (rare liver toxicity). Discuss before use. Acupuncture has mixed evidence but helps some women. 6) How to choose and what to tell your clinician Important medical history that changes recommendations: breast cancer, history of blood clots or stroke, heart disease, liver disease, migraine with aura, current medications (especially tamoxifen). If you have a uterus and want systemic estrogen, you’ll need progestogen as well (or an IUD). If you had a hysterectomy, estrogen alone is an option. At age 47 you may be perimenopausal (cycles irregular) — this is common; labs (FSH, estradiol) are rarely required unless the diagnosis is unclear. If hot flashes and sleep problems are severe, a primary care doctor or gynecologist can prescribe MHT or a non‑hormonal medication; consider referral to a menopause specialist if complex. Next steps I can help with If you want, tell me: do you still have periods? Any history of breast cancer, blood clots, stroke, heart disease, or migraines with aura? Any current medications (especially tamoxifen) or sleep medications? With that I can suggest a targeted regimen (e.g., a transdermal estradiol patch + micronized progesterone vs. venlafaxine vs. gabapentin) and pros/cons for you.

Mentioned in position 5 of 17

Read full answer with sources →

Public AI visibility history

Daily rank of EstroGel on our buyer intent questions, per category. A dash means the engines did not cite EstroGel at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Menopause and women's health#32#19
BHRT#65

TL;DR

EstroGel is a prescription transdermal estradiol gel used in hormone therapy for menopausal women, manufactured by Ascend Therapeutics and sold under the brand at estrogel.com. Its core product delivers bioidentical estradiol through the skin to relieve common menopause symptoms. According to WellRank's latest index, EstroGel ranks 12th in the Menopause and Women's Health category with 8% AI visibility, and the tone of AI mentions in the WellRank corpus skews positive, with two positive mentions and one neutral.

Company Overview

EstroGel is a branded prescription pharmaceutical product marketed by Ascend Therapeutics, a specialty women's health company. The product is distributed through traditional pharmacy channels and requires a physician prescription, reflecting a standard branded-drug commercial model. Ascend Therapeutics focuses specifically on women's health therapeutics, positioning EstroGel as a cornerstone of its portfolio.

Product Features

  • Estradiol gel 0.06% delivered via a metered-dose pump for consistent dosing
  • Transdermal application to the skin, typically the upper arm, avoiding first-pass liver metabolism
  • Bioidentical estradiol as the active hormone, chemically identical to the estrogen the body produces
  • Once-daily application regimen intended to support adherence
  • Available in a multi-dose pump format that measures each dose precisely

Target Market

EstroGel is indicated for women experiencing moderate to severe vasomotor symptoms associated with menopause, most commonly hot flashes and night sweats. It is a prescription product available in the United States and is primarily used by peri- and post-menopausal women under physician supervision. Women who prefer a non-oral, non-patch route of estrogen administration are a key segment.

Buyer Personas

  • A post-menopausal woman in her early 50s seeking relief from frequent hot flashes who prefers a topical gel over daily pills.
  • A perimenopausal patient whose gynecologist recommended a transdermal estrogen option to avoid gastrointestinal side effects associated with oral hormone therapy.
  • A women's health clinician or OB-GYN evaluating bioidentical transdermal estrogen products to prescribe for patients with cardiovascular risk factors that make oral estrogens less desirable.
  • A health-conscious woman who has researched hormone therapy options online and specifically requested a bioidentical, non-patch gel from her provider.

Funding & Performance

Ascend Therapeutics is a privately held specialty pharmaceutical company; detailed funding history, valuation, and revenue figures are not publicly disclosed.

Recent Developments

Ascend Therapeutics has maintained EstroGel's presence in the branded hormone therapy market as awareness of menopause care and hormone replacement therapy has grown broadly. The product has benefited from renewed public and clinical interest in menopause management, including updated guidance from major menopause societies on the benefits and safety of hormone therapy for appropriate candidates. No specific recent pipeline announcements or formulation changes are widely reported.

Competitive Landscape

According to WellRank's co-mention data, EstroGel most frequently appears alongside Vivelle-Dot, Climara, Divigel, Estrace, Premarin, Prometrium, Vagifem, and Testim in AI-generated answers about menopause and hormone therapy. Divigel is its most direct competitor as another prescription estradiol gel, while Vivelle-Dot and Climara compete in the transdermal patch segment. Oral options such as Premarin and Estrace represent a broader but overlapping competitive set, with the overall category reflecting a crowded branded and generic hormone therapy market.

EstroGel vs the brands AI recommends alongside it

The real competitive set in Menopause and women's health: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
EstroGel logo
EstroGelThis brand
#19
8.3%
Climara logo
Climara

3 shared answers

#7
16.7%
Prometrium logo
Prometrium

3 shared answers

#9
16.7%
Vivelle-Dot logo
Vivelle-Dot

3 shared answers

#6
16.7%
Divigel logo
Divigel

2 shared answers

#25
8.3%

Email me when overtakes EstroGel

One email the day the ranks flip. Nothing else.

User Sentiment

Within the WellRank corpus, EstroGel's AI mentions trend positive, with two of three tracked mentions carrying a positive tone and one neutral, and no cautious or mixed characterizations recorded. Reviews and patient discussions found across health platforms generally reflect appreciation for the gel's ease of application and its bioidentical formulation. AI engines tend to surface EstroGel as a credible, established transdermal option within broader menopause treatment comparisons, consistent with its ranking of 12th in the WellRank Menopause and Women's Health category.

Pricing

EstroGel is a branded prescription product; out-of-pocket cost depends on insurance coverage, pharmacy, and any available manufacturer savings programs. Exact retail or co-pay figures are not published in a stable, universally applicable way and pricing varies by payer and dispensing pharmacy.

Sources cited around EstroGel

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track EstroGel weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at EstroGel? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.